title: Argon plasma ablation of gastric inlet patches in the cervical esophagus may alleviate globus sensation: a pilot trial.
abstract: OBJECTIVE
  Globus sensation and/or sore throat have been associated with both gastroesophageal reflux disease and the presence of a gastric inlet patch. There have been no reports, however, on whether ablation of heterotopic mucosa in the cervical esophagus leads to improvement of chronic globus sensation.
  
  
  METHODS
  Ten patients with a histologically proved gastric inlet patch who complained of chronic globus sensation and/or sore throat were included in this prospective pilot study. After a thorough assessment, including videofluoroscopy, laryngoscopy, manometry, and 24-hour two-channel pH monitoring, patients underwent argon plasma coagulation (APC) to ablate the heterotopic mucosa. A questionnaire with a visual analog scale ranging from 0 to 10 was used for assessment of globus sensation, sore throat, and other typical or atypical reflux symptoms. Follow-up examinations (including symptom assessment) were performed 4 weeks and 8 weeks after APC therapy.
  
  
  RESULTS
  Ablation of the gastric inlet patch resulted in a significant reduction of median symptom scores for globus sensation (from 2.7 to 0) and sore throat (from 2.8 to 0) 8 weeks after therapy ( P < 0.05), but there was no improvement in other reflux-related symptoms. Acid reflux in the distal and proximal esophagus, determined by two-channel pH monitoring, did not change after therapy.
  
  
  CONCLUSIONS
  Our preliminary data suggest that ablation of gastric inlet patches by APC can alleviate chronic globus sensation or sore throat. Acid reflux or its treatment is unlikely to influence these results. A randomized and blinded study is warranted.
authors.affiliation: Department of Medicine II, Klinikum rechts der Isar, Technical University of Munich, Germany. alexander.meining@lrz.tum.de
authors.forename: A
authors.initials: A
authors.lastname: Meining
authors.forename: M
authors.initials: M
authors.lastname: Bajbouj
authors.forename: M
authors.initials: M
authors.lastname: Preeg
authors.forename: J
authors.initials: J
authors.lastname: Reichenberger
authors.forename: A M
authors.initials: AM
authors.lastname: Kassem
authors.forename: W
authors.initials: W
authors.lastname: Huber
authors.forename: S J
authors.initials: SJ
authors.lastname: Brockmeyer
authors.forename: C
authors.initials: C
authors.lastname: Hannig
authors.forename: H
authors.initials: H
authors.lastname: Höfler
authors.forename: C
authors.initials: C
authors.lastname: Prinz
authors.forename: R M
authors.initials: RM
authors.lastname: Schmid
mesh_terms: D000328:Adult; D000368:Aged; D016099:Endoscopy, Gastrointestinal; D004947:Esophagus / Q000378:metabolism / Q000503:physiopathology / Q000601:surgery*; D005260:Female; D005500:Follow-Up Studies; D005753:Gastric Mucosa / Q000473:pathology / Q000601:surgery*; D005764:Gastroesophageal Reflux / Q000150:complications* / Q000503:physiopathology / Q000601:surgery; D006801:Humans; D006863:Hydrogen-Ion Concentration; D006984:Hypertrophy; D007828:Laryngoscopy; D017075:Laser Coagulation / Q000379:methods*; D008297:Male; D008365:Manometry; D008875:Middle Aged; D010612:Pharyngitis / Q000209:etiology / Q000503:physiopathology / Q000601:surgery*; D010865:Pilot Projects; D011312:Pressure; D011446:Prospective Studies; D011795:Surveys and Questionnaires; D016896:Treatment Outcome